Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03864016Completed
Randomised trial of sufentanil in pain (2 arms), sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Primary endpoint: Total dose of sufentanil required per operation. Started Mar 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03864016.